Search Results - "Pushko, Peter"

Refine Results
  1. 1

    Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development by Pushko, Peter, Tretyakova, Irina

    Published in Viruses (08-05-2020)
    “…In the midst of the ongoing COVID-19 coronavirus pandemic, influenza virus remains a major threat to public health due to its potential to cause epidemics and…”
    Get full text
    Journal Article
  2. 2

    Development of virus-like particle technology from small highly symmetric to large complex virus-like particle structures by Pushko, Peter, Pumpens, Paul, Grens, Elmars

    Published in Intervirology (01-01-2013)
    “…Virus-like particle (VLP) technology is a promising approach for the construction of novel vaccines, diagnostic tools, and gene therapy vectors. Initially,…”
    Get more information
    Journal Article
  3. 3

    Replication of the Venezuelan Equine Encephalitis Vaccine from a Synthetic PCR Fragment by Mathew, Christine, Tucker, Colin, Tretyakova, Irina, Pushko, Peter

    Published in Pharmaceutics (17-09-2024)
    “…There is no approved human vaccine for Venezuelan equine encephalitis (VEE), a life-threatening disease caused by the VEE virus (VEEV). In previous studies,…”
    Get full text
    Journal Article
  4. 4

    Single-Dose Immunogenic DNA Vaccines Coding for Live-Attenuated Alpha- and Flaviviruses by Pushko, Peter, Lukashevich, Igor S, Johnson, Dylan M, Tretyakova, Irina

    Published in Viruses (01-03-2024)
    “…Single-dose, immunogenic DNA (iDNA) vaccines coding for whole live-attenuated viruses are reviewed. This platform, sometimes called immunization DNA, has been…”
    Get full text
    Journal Article
  5. 5

    A Novel Application of Virus Like Particles in the Hemagglutination Inhibition Assay by El-Husseiny, Mohamed H, Pushko, Peter, Tretyakova, Irina, Hagag, Naglaa M, Abdel-Mawgod, Sara, Shabaan, Ahmed, Bakry, Neveen R, Arafa, Abdel Satar

    “…The hemagglutination inhibition (HI) assay is a traditional laboratory procedure for detection and quantitation of serum antibodies of hemagglutinating viruses…”
    Get full text
    Journal Article
  6. 6

    Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle by Kim, Ki-Hye, Li, Zhuo, Bhatnagar, Noopur, Subbiah, Jeeva, Park, Bo Ryoung, Shin, Chong Hyun, Pushko, Peter, Wang, Bao-Zhong, Kang, Sang-Moo

    Published in PLoS pathogens (01-08-2022)
    “…Annual influenza vaccination is recommended to update the variable hemagglutinin antigens. Here, we first designed a virus-like particle (VLP) displaying…”
    Get full text
    Journal Article
  7. 7

    Live-attenuated CHIKV vaccine with rearranged genome replicates in vitro and induces immune response in mice by Tretyakova, Irina, Joh, Joongho, Gearon, Mary, Kraenzle, Jennifer, Goedeker, Sidney, Pignataro, Ava, Alejandro, Brian, Lukashevich, Igor S, Chung, Donghoon, Pushko, Peter

    Published in PLoS neglected tropical diseases (01-04-2024)
    “…Chikungunya fever virus (CHIKV) is a mosquito-borne alphavirus that causes wide-spread human infections and epidemics in Asia, Africa and recently, in the…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus Challenge by PERRONE, Lucy A, AHMAD, Attiya, VEGUILLA, Vic, XIUHUA LU, SMITH, Gale, KATZ, Jacqueline M, PUSHKO, Peter, TUMPEY, Terrence M

    Published in Journal of Virology (01-06-2009)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  10. 10

    Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle by Bright, Rick A, Carter, Donald M, Crevar, Corey J, Toapanta, Franklin R, Steckbeck, Jonathan D, Cole, Kelly S, Kumar, Niranjan M, Pushko, Peter, Smith, Gale, Tumpey, Terrence M, Ross, Ted M

    Published in PloS one (30-01-2008)
    “…Vaccination is a cost-effective counter-measure to the threat of seasonal or pandemic outbreaks of influenza. To address the need for improved influenza…”
    Get full text
    Journal Article
  11. 11

    Evaluation of Protective Efficacy of Influenza Virus Like Particles Prepared from H5N1 Virus of Clade 2.2.1.2 in Chickens by El-Husseiny, Mohamed H., Hagag, Naglaa M., Pushko, Peter, Tretyakova, Irina, Naguib, Mahmoud M., Arafa, Abdel Satar

    Published in Vaccines (Basel) (01-07-2021)
    “…Highly pathogenic Avian Influenza (HPAI) viruses continue to cause severe economic losses in poultry species worldwide. HPAI virus of subtype H5N1 was reported…”
    Get full text
    Journal Article
  12. 12

    Evaluation in nonhuman primates of vaccines against Ebola virus by Geisbert, Thomas W, Pushko, Peter, Anderson, Kevin, Smith, Jonathan, Davis, Kelly J, Jahrling, Peter B

    Published in Emerging infectious diseases (01-05-2002)
    “…Ebola virus (EBOV) causes acute hemorrhagic fever that is fatal in up to 90% of cases in both humans and nonhuman primates. No vaccines or treatments are…”
    Get full text
    Journal Article
  13. 13

    Advanced Safety and Genetic Stability in Mice of a Novel DNA-Launched Venezuelan Equine Encephalitis Virus Vaccine with Rearranged Structural Genes by Johnson, Dylan M, Sokoloski, Kevin J, Jokinen, Jenny D, Pfeffer, Tia L, Chu, Yong-Kyu, Adcock, Robert S, Chung, Donghoon, Tretyakova, Irina, Pushko, Peter, Lukashevich, Igor S

    Published in Vaccines (Basel) (02-03-2020)
    “…The safety and genetic stability of V4020, a novel Venezuelan Equine Encephalitis Virus (VEEV) vaccine based on the investigational VEEV TC-83 strain, was…”
    Get full text
    Journal Article
  14. 14

    Incorporation of High Levels of Chimeric Human Immunodeficiency Virus Envelope Glycoproteins into Virus-Like Particles by Wang, Bao-Zhong, Liu, Weimin, Kang, Sang-Moo, Alam, Munir, Huang, Chunzi, Ye, Ling, Sun, Yuliang, Li, Yingying, Kothe, Denise L, Pushko, Peter, Dokland, Terje, Haynes, Barton F, Smith, Gale, Hahn, Beatrice H, Compans, Richard W

    Published in Journal of Virology (01-10-2007)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  15. 15

    Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola Viruses by Pushko, P, Geisbert, J, Parker, M, Jahrling, P, Smith, J

    Published in Journal of Virology (01-12-2001)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  16. 16

    Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus by Pushko, Peter, Bray, Mike, Ludwig, George V, Parker, Michael, Schmaljohn, Alan, Sanchez, Anthony, Jahrling, Peter B, Smith, Jonathan F

    Published in Vaccine (15-08-2000)
    “…RNA replicons derived from an attenuated strain of Venezuelan equine encephalitis virus (VEE), an alphavirus, were configured as candidate vaccines for Ebola…”
    Get full text
    Journal Article
  17. 17

    Candidate Vaccine against Botulinum Neurotoxin Serotype A Derived from a Venezuelan Equine Encephalitis Virus Vector System by LEE, John S, PUSHKO, Peter, PARKER, Michael D, DERTZBAUGH, Mark T, SMITH, Leonard A, SMITH, Jonathan F

    Published in Infection and Immunity (01-09-2001)
    “…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  18. 18

    Plasmid DNA launches live-attenuated Japanese encephalitis virus and elicits virus-neutralizing antibodies in BALB/c mice by Nickols, Brian, Tretyakova, Irina, Tibbens, Alexander, Klyushnenkova, Elena, Pushko, Peter

    Published in Virology (New York, N.Y.) (01-12-2017)
    “…We describe novel plasmid DNA that encodes the full-length Japanese encephalitis virus (JEV) genomic cDNA and launches live-attenuated JEV vaccine in vitro and…”
    Get full text
    Journal Article
  19. 19

    Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins by Wang, Min, Jokinen, Jenny, Tretyakova, Irina, Pushko, Peter, Lukashevich, Igor S.

    Published in Vaccine (29-01-2018)
    “…•High genetic diversity of LASV is one of the great challenges for vaccine R&D.•VEEV TC-83 vaccine was used to design bivalent virus-like-particle-vectors,…”
    Get full text
    Journal Article
  20. 20

    DNA Vaccine Initiates Replication of Live Attenuated Chikungunya Virus In Vitro and Elicits Protective Immune Response in Mice by Tretyakova, Irina, Hearn, Jason, Wang, Eryu, Weaver, Scott, Pushko, Peter

    Published in The Journal of infectious diseases (15-06-2014)
    “…Background. Chikungunya virus (CHIKV) causes outbreaks of chikungunya fever worldwide and represents an emerging pandemic threat. Vaccine development against…”
    Get full text
    Journal Article